CIPROCET

This brand name is authorized in Nigeria.

Active ingredients

The drug CIPROCET contains one active pharmaceutical ingredient (API):

1	Ciprofloxacin UNII 4BA73M5E37 - CIPROFLOXACIN HYDROCHLORIDE
	Ciprofloxacin is a fluoroquinolone antibacterial agent. The bactericidal action of ciprofloxacin results from the inhibition of both type II topoisomerase (DNA-gyrase) and topoisomerase IV, required for bacterial DNA replication, transcription, repair and recombination.
	Read more about Ciprofloxacin

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-0290	Ear/eye drops	CIPROCET EYE & EAR DROPS SOL_DROPS 0.3% 1 x 5ML PET BOTTLE	27 RNW-PP-246433 CIPROCET EYE & EAR DROPS CIPROFLOXACIN 0.3%W/V CIPROFLOXACIN HYDROCHLORIDE USP EQ. TO CIPROFLOXACIN 0.3%W/V BENZALKONIUM CHLORIDE NF 0.01%W/V A4-0290 Drugs ANTIINFECTIVES FOR SYSTEMIC USE Imported Products 1 x 5ML PET BOTTLE Prescription Only Medicine (POM) 1/11/2022 MERIT HEALTHCARE LTD, Iya-Oba House, 10 Dele Ashiru Street, Ire-Akari Estate, Isolo 8171273639 casmolar1@yahoo.com Ciron Drugs & Pharmaceuticals Pvt. Ltd., N-118, M.I.D.C.,TARAPUR, BOISAR,DIST. THANE - 401 506. MAHARASHTRA, INDIA, India	28/03/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
S03AA07	Ciprofloxacin	S Sensory organs → S03 Ophthalmological and otological preparations → S03A Antiinfectives → S03AA Antiinfectives
Discover more medicines within S03AA07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-0290